...
首页> 外文期刊>Asia-Pacific Biotech News >Asian American Medical Group returns to the black with SELLER0.6M net profit for FY2015; revenue up 65% on strong demand for liver treatment services
【24h】

Asian American Medical Group returns to the black with SELLER0.6M net profit for FY2015; revenue up 65% on strong demand for liver treatment services

机译:亚美医疗集团在2015财年净利润为SELLER0.6M的情况下又扭亏为盈;由于对肝脏治疗服务的强劲需求,营业收入增长了65%

获取原文
获取原文并翻译 | 示例
           

摘要

SINGAPORE - ASX-listed Asian American Medical Group Limited ("AAMG" and together with its subsidiaries, the "Group") announced a net profit of S$0.6 million for the 12 months ended 31 August 2015 ("FY2015"), reversing the previous year's net loss of SELLER2.5 million, thanks toa surge in demand for its liver treatment services. AAMG's Asian American Blood Et Bone Marrow Transplant Centre Pte Ltd ("AABMTC") ceased operations on 31 December 2014 and was classified under discontinued operations. The Group recorded a ELLER0.5 million loss from discontinuedoperations. Without this loss, the Group would have achieved a net profit of $1.1 million from continuing operations in FY2015.
机译:新加坡-在澳交所上市的亚裔美国人医疗集团有限公司(“ AAMG”)及其子公司,“集团”)宣布截至2015年8月31日的12个月(2015财年)净利润为60万新元。由于对其肝脏治疗服务的需求激增,本年度的净亏损为SELLER250万。 AAMG的亚裔美国人血液和骨髓移植中心私人有限公司(“ AABMTC”)于2014年12月31日停止运营,被归类为已终止经营。本集团因非持续经营而录得ELLER0.5百万亏损。如果没有这种损失,该集团将在2015财年实现持续经营净利润110万美元。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号